Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
FDA Approvals
FDA Approvals
Sarclisa Newest Treatment Approved by the FDA for Patients with Multiple Myeloma
Read More
FDA Approvals
,
In the News
Tazverik Receives FDA Approval as First Treatment Specifically for Metastatic or Locally Advanced Epithelioid Sarcoma
Read More
FDA Approvals
,
In the News
Mixed Findings in Annual Cancer Statistics Report
Read More
FDA Approvals
,
In the News
FDA Grants Approval to Avapritinib for Patients with GIST
Read More
FDA Approvals
,
In the News
Recap of FDA Drug Approvals in 2019
Read More
FDA Approvals
,
In the News
Regenerative Medicine Advanced Therapy Designation Granted to ADP-A2M4 for Synovial Sarcoma
Read More
FDA Approvals
,
In the News
November 11, 2019 — Oncology News & Updates
Read More
FDA Approvals
,
In the News
October 28, 2019 – Oncology News & Updates
Read More
Breast Cancer
,
FDA Approvals
,
In the News
,
Multiple Myeloma
,
Pediatric Cancer
,
Oncology
Vincristine, Racial Disparities in Multiple Myeloma, and HER2 Metastatic Breast Cancer Are in the News
Read More
FDA Approvals
,
Multiple Myeloma
,
In the News
,
Oncology
FDA Approves Darzalex Combination for First-Line Treatment of Transplant-Eligible Patients with Multiple Myeloma
Read More
9
10
11
12
13
14
15
Page 12 of 21
Results 111 - 120 of 202
